中财网 中财网股票行情
迪哲医药(688192)财务分析指标    年份：
截止日期2026-06-302026-03-312025-12-312025-09-302025-06-30
营业总收入(万元)52269.2725252.1980113.5658630.1135500.14
营业收入(万元)52269.2725252.1980113.5658630.1135500.14
营业总成本(万元)75930.4636528.73165417.85123549.0177960.71
营业成本(万元)2089.111029.053422.892532.521562.74
净利润(万元)-21037.34-9555.74-76404.95-57994.78-37736.01
归属于母公司的净利润(万元)-21037.34-9555.74-76404.95-57994.78-37736.01
营业利润(万元)-21262.47-9636.64-76636.27-58290.11-37899.03
利润总额(万元)-21246.22-9634.23-76712.67-58290.11-37899.03
少数股东损益(万元)-272.22-114.48-446.80-300.54-168.23
基本每股收益(元)-0.45(元)-0.21(元)-1.71(元)-1.32(元)-0.87(元)
稀释每股收益(元)-0.45(元)-0.21(元)-1.71(元)-1.32(元)-0.87(元)
非经常性损益(万元)--1327.52--5071.31--
扣除非经常性损益后净利润(万元)-23123.66-10883.26-84155.30-63066.09-41923.13
总资产(万元)284786.30301301.97300252.92295534.66321846.06
总负债(万元)171874.27177783.89170683.83151161.32158968.31
归属于母公司股东权益合计(万元)113000.93123449.25129385.77144043.77162415.87
股东权益合计(万元)112912.03123518.08129569.08144373.34162877.75
实收资本(股本)(万元)46516.5846463.3346118.7945941.2945941.29
资本公积(万元)499878.75498898.72495624.05492049.38490162.71
未分配利润(万元)-433394.40-421912.80-412357.06-393946.89-373688.13
经营活动产生的现金流量净额(万元)-27430.78-20047.76-58832.48-42405.68-26466.94
经营活动现金流入小计(万元)53917.7426906.6284612.7459511.6738202.22
经营活动现金流出小计(万元)81348.5146954.38143445.22101917.3664669.16
投资活动产生的现金流量净额(万元)5523.91-9343.45-119870.88-45203.33-51722.78
投资活动现金流入小计(万元)364353.62189647.90996876.02728291.00363160.46
投资活动现金流出小计(万元)358829.71198991.351116746.90773494.33414883.24
筹资活动产生的现金流量净额(万元)10705.1322634.62182868.49164090.84177637.57
筹资活动现金流入小计(万元)47250.8142530.81260414.35233358.57233358.57
筹资活动现金流出小计(万元)36545.6819896.1977545.8669267.7355721.01
期末现金及现金等价物余额(万元)17886.4122342.2129114.66101448.46124429.09
最后修改日期2026-08-202026-04-302026-03-302025-11-012025-08-22
↑返回页顶↑

转至迪哲医药（688192）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。